An old steroid treatment, long available outside the United States, received approval this week for a rare disease that afflicts about 15,000 Americans. The new list price for the drug? $89,000 a year.
An old steroid treatment, long available outside the United States, received approval this week for a rare disease that afflicts about 15,000 Americans. The new list price for the drug? $89,000 a year.